BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 7013871)

  • 1. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
    Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
    Storb R; Blume KG; O'Donnell MR; Chauncey T; Forman SJ; Deeg HJ; Hu WW; Appelbaum FR; Doney K; Flowers ME; Sanders J; Leisenring W
    Biol Blood Marrow Transplant; 2001; 7(1):39-44. PubMed ID: 11215697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unrelated bone marrow transplantation in two severe aplastic anemia patients preconditioned with a regimen of cyclophosphamide, antithymocyte globulin, and total body irradiation].
    Mizue N; Watanabe J; Katoh S; Oda T; Suzuki N; Kudoh T
    Rinsho Ketsueki; 1999 Mar; 40(3):213-7. PubMed ID: 10222628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
    Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
    Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A; Ortega Aramburu JJ; Bureo Dacal E; Badell Serra I; Madero López L; Olive Oliveras T; Cubells Riero J; Maldonado Regalado MS; Ramírez Orellana M
    An Esp Pediatr; 1999 Jan; 50(1):29-32. PubMed ID: 10083639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for severe aplastic anemia in Japan.
    Kanamaru A; Nagai K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclophosphamide and total lymph node irradiation as conditioning for bone marrow transplant in severe aplastic anemia].
    Sotti G; Rigon A; Polico C; Scarzello G; Friso ML; Calzavara F; Fabbris R; Cauzzo C
    Radiol Med; 1987 Jun; 73(6):545-6. PubMed ID: 3299513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.
    Aki SZ; Sucak GT; Ozkurt ZN; Yeğin ZA; Yağci M; Haznedar R
    Transfus Apher Sci; 2009 Feb; 40(1):5-11. PubMed ID: 19121979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.